Introduction
Diagnosis of HIV infection in Africa is often made at the hospital level, when individuals often have advanced stages of clinical disease and immunosuppression. The management of individuals in late stages of disease progression is complicated, and treatment outcomes are likely to be less successful than if these individuals were detected early. In some countries in sub-Saharan Africa, 70% of hospital-related admissions are HIV-linked, and the related mortality is as high as 68%. 1, 2 The health centre is the first-line health facility that is often the most accessible to the population. Thus, the first contact of an ill person who is HIV-positive but whose status is unknown is most likely to occur at such centres. If those who are likely to be HIV positive could be identified on the basis of simple clinical findings, they could be encouraged to undergo voluntary counselling and HIV testing (VCT). 3, 4 This would serve as a gateway to early diagnosis of HIV infection and access to a number of prevention and care interventions. First, they could be offered cotrimoxazole prophylaxis 5, 6 for the prevention of HIV-related opportunistic infections. Second, isoniazid preventive therapy could be offered to prevent reactivation TB. 7 Third, HIV-positive individuals could be prepared to start antiretroviral therapy (ART) when they become eligible. 8 Fourth, people in a stable relationship can take steps to protect their partner from becoming infected, and they could also avoid mother-tochild transmission of the virus.
This study was conducted among individuals attending a health centre facility in urban Nairobi, in order to (a) determine the prevalence of HIV, (b) identify clinical risk factors associated with HIV and (c) determine clinical markers that could be useful for clinical screening of HIV at the health centre level.
Materials and methods
The study was conducted between May and August 1998 at Dandora Health Centre, a primary health-care facility in an urban suburb of Nairobi, Kenya. The centre is a public health facility offering free health-care services including general outpatient consultations, mother and child health services, management of sexual transmitted infections and TB treatment. All consecutive patients presenting at the health centre on randomly selected days of the week were involved in the study.
All individuals once managed for their principal complaint were referred to a VCT unit where they received pre-test counselling. Those 
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Materials and methods
All individuals once managed for their principal complaint were referred to a VCT unit where they received pre-test counselling. Those who accepted HIV testing underwent post-test counselling. HIV serology was performed using a combination of a rapid test (Capillus, Cambridge Diagnostics Ltd, Galway, Ireland) and an enzyme-linked immunosorbent assay (Innotest,
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Innogenetics, Gent, Belgium). The choice of tests and testing procedures were in accordance with World Health Organization (WHO) recommendations. 8 Interviewer-administered questionnaires (which had been pre-tested) and a record form were used to gather information on sociodemographic data, past medical history and clinical findings included in the WHO clinical staging 9 of HIV disease. Analysis was done using the Epi-Info (CDC, Atlanta, USA), and the STATA 8.0 (Stata Corporation, College Station, USA) softwares. Crude and adjusted odds ratios were determined using stepwise logistic regression analysis. Sensitivity, specificity, positive and negative predictive values of medical conditions were determined using positive HIV serology as the reference standard.
Results
A total of 304 patients were involved in the study, of whom there were 232 (77%) women and 71 men (median age; 25 years, range 15-60). There were 107 (35%) individuals who were HIV positive including 88 (38%) women and 19 men.
Risk factors associated with an HIV-positive status, as well as their positive and negative predictive values, are shown in Table 1 . Four medical conditions were found to be independent risk factors for HIV seropositivity. This included oral thrush, past or present herpes zoster, past or present TB and chronic genital herpes.
Oral thrush, past or present history of herpes zoster, past or present TB and severe prurigo were the most discriminating conditions associated with HIV ( Figure 1 ). In all, 61 (63%) of 97 individuals presenting with at least one of these four medical conditions were HIV positive. A screening algorithm using these four medical conditions would pick out 61 (57%) of the 107 HIV-positive individuals who attended the health centre in the study period (sensitivity ¼ 57%, specificity ¼ 82%, positive predictive value ¼ 63%, negative predictive value ¼ 78%).
A patient who presented with any one of those four medical conditions had an odds ratio of 5.93 (95% confidence interval 3.50-10.04) for being seropositive compared with individuals without those conditions. This study shows that one in three individuals attending a health centre in urban Kenya are HIV positive. Targeting VCT to clinical subgroups of individuals having past or present herpes zoster, past or present TB, oral thrush and prurigo would detect more than half of all these HIVpositive individuals. Present or past history of herpes zoster and TB are easy to diagnose, as patients are often able to recall having had these two conditions. In particular, the scar of past herpes zoster can also be verified by physical examination, and it is often possible to confirm a history of TB through patient identification cards and the TB register. Oral thrush and prurigo can be detected by simple oral examination and inspection of the skin, respectively. Screening using such clinical markers should thus be feasible in health centres in Kenya where clinical acumen is often limited, staff are overworked and resources are limited.
The WHO has set an ambitious target of offering 3 million people ART by 2005. 8 This will invariably have to involve a scaling-up process involving simplification of HIV/AIDS interventions and eventual decentralization to the health centre level. Confirmed HIV-positive individuals who have clinical markers identified in this study would fall into WHO stages II-IV and would thus be eligible for cotrimoxazole prophylaxis, 10 isoniazid prophylaxis 7 and eventually ART.
In a resource-poor setting, introducing a clinical screening algorithm for HIV at the health centre level using four simple clinical markers could provide an opportunity for targeted VCT and early access to a range of prevention and care interventions.
Introduction
Ophthalmia neonatorum is a form of conjunctivitis occurring in neonatal period. It is the most common cause of acute ophthalmic disease in newborns. The reported incidence of this disease varies, from 1.6% in USA to 23% over the world, and in some studies even 25.6%. [1] [2] [3] There have been many different aetiologic agents implicated that differ greatly in their virulence and clinical course. [4] [5] [6] [7] [8] The aetiologic agents include bacteria, viruses and chemical compounds. The most
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